• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏中和活性的轮状病毒VP6特异性IgA单克隆抗体的保护作用。

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

作者信息

Burns J W, Siadat-Pajouh M, Krishnaney A A, Greenberg H B

机构信息

Department of Medicine, Stanford University School of Medicine, CA 94305, USA.

出版信息

Science. 1996 Apr 5;272(5258):104-7. doi: 10.1126/science.272.5258.104.

DOI:10.1126/science.272.5258.104
PMID:8600516
Abstract

Rotaviruses are the leading cause of severe gastroenteritis and dehydrating diarrhea in young children and animals worldwide. A murine model and "backpack tumor" transplantation were used to determine the protective effect of antibodies against VP4(an outer capsid viral protein) and VP6(a major inner capsid viral protein). Only two non-neutralizing immunoglobulin A (IgA) antibodies to VP6 were capable of preventing primary and resolving chronic murine rotavirus infections. These antibodies were not active, however, when presented directly to the luminal side of the intestinal tract. These findings support the hypothesis that in vivo intracellular viral inactivation by secretory IgA during transcytosis is a mechanism of host defense against rotavirus infection.

摘要

轮状病毒是全球范围内导致幼儿和动物严重肠胃炎及脱水腹泻的主要原因。利用小鼠模型和“背包肿瘤”移植来确定针对VP4(一种病毒外衣壳蛋白)和VP6(一种主要的病毒内衣壳蛋白)的抗体的保护作用。只有两种针对VP6的非中和性免疫球蛋白A(IgA)抗体能够预防原发性小鼠轮状病毒感染并解决慢性感染。然而,当这些抗体直接作用于肠道管腔侧时并无活性。这些发现支持了以下假说:在转胞吞过程中,分泌型IgA在体内对病毒进行细胞内灭活是宿主抵御轮状病毒感染的一种机制。

相似文献

1
Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.缺乏中和活性的轮状病毒VP6特异性IgA单克隆抗体的保护作用。
Science. 1996 Apr 5;272(5258):104-7. doi: 10.1126/science.272.5258.104.
2
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.一种非中和性、轮状病毒VP6特异性IgA单克隆抗体对轮状病毒复制的抑制作用
J Clin Invest. 2002 May;109(9):1203-13. doi: 10.1172/JCI14397.
3
Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea.抗轮状病毒免疫球蛋白A在通过上皮细胞转胞吞作用后可在体外中和病毒,并保护幼鼠免受腹泻之苦。
J Virol. 1998 Apr;72(4):2708-14. doi: 10.1128/JVI.72.4.2708-2714.1998.
4
Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.轮状病毒抗-VP6分泌型免疫球蛋白A通过细胞内中和而非免疫排斥发挥保护作用。
J Virol. 2006 Nov;80(21):10692-9. doi: 10.1128/JVI.00927-06. Epub 2006 Sep 6.
5
Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.针对轮状病毒中层蛋白VP6引发的免疫反应可在体外和体内抑制病毒复制。
Hum Vaccin Immunother. 2014;10(7):2039-47. doi: 10.4161/hv.28858.
6
Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.用轮状病毒VP6进行粒子轰击介导的DNA疫苗接种可诱导高水平的血清轮状病毒IgG,但不能保护小鼠免受攻击。
Virology. 1997 May 26;232(1):129-38. doi: 10.1006/viro.1997.8552.
7
Protective immunity induced by rotavirus DNA vaccines.轮状病毒DNA疫苗诱导的保护性免疫。
Vaccine. 1997 Jun;15(8):899-902. doi: 10.1016/s0264-410x(96)00272-1.
8
Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.轮状病毒内壳蛋白诱导的异源保护需要黏膜免疫球蛋白的转胞吞作用。
J Virol. 2002 Aug;76(16):8110-7. doi: 10.1128/jvi.76.16.8110-8117.2002.
9
Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.轮状病毒2/6病毒样颗粒与CT-E29H(一种解毒霍乱毒素佐剂)联合使用的保护效力。
Viral Immunol. 2001;14(1):31-47. doi: 10.1089/08828240151061365.
10
Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.人IgA对轮状病毒的中和作用以及对VP4和VP7上免疫重要表位的识别。
Arch Virol. 1997;142(7):1491-8. doi: 10.1007/s007050050175.

引用本文的文献

1
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus.工程化二聚体IgA的母乳递送可保护新生儿免受轮状病毒感染。
Mucosal Immunol. 2025 Apr;18(2):441-452. doi: 10.1016/j.mucimm.2025.01.002. Epub 2025 Jan 20.
2
Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.用于生产抗A组轮状病毒亚单位疫苗的生物技术干预措施。
Cell Biochem Funct. 2024 Dec;42(8):e70031. doi: 10.1002/cbf.70031.
3
Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers.
人类和动物轮状病毒疫苗的最新进展洞察:探索新领域
Virol Sin. 2025 Feb;40(1):1-14. doi: 10.1016/j.virs.2024.12.001. Epub 2024 Dec 11.
4
Genetic and antigenic characterization of two diarrhoeicdominant rotavirus A genotypes G3P[12] and G14P[12] circulating in the global equine population.在全球马群中流行的两种以腹泻为主的轮状病毒 A 基因型 G3P[12]和 G14P[12]的遗传和抗原特征。
J Gen Virol. 2024 Aug;105(8). doi: 10.1099/jgv.0.002016.
5
Antibody-mediated control mechanisms of viral infections.病毒感染的抗体介导控制机制。
Immunol Rev. 2024 Nov;328(1):205-220. doi: 10.1111/imr.13383. Epub 2024 Aug 20.
6
Chimeric Viruses Enable Study of Antibody Responses to Human Rotaviruses in Mice.嵌合病毒使在小鼠中研究针对人类轮状病毒的抗体反应成为可能。
Viruses. 2024 Jul 16;16(7):1145. doi: 10.3390/v16071145.
7
Generation of single-round infectious rotavirus with a mutation in the intermediate capsid protein VP6.产生单个轮次感染性轮状病毒,其中中间衣壳蛋白 VP6 发生突变。
J Virol. 2024 Jul 23;98(7):e0076224. doi: 10.1128/jvi.00762-24. Epub 2024 Jun 5.
8
Single domain antibodies from camelids in the treatment of microbial infections.骆驼科单域抗体在治疗微生物感染中的应用。
Front Immunol. 2024 May 17;15:1334829. doi: 10.3389/fimmu.2024.1334829. eCollection 2024.
9
VP4 Mutation Boosts Replication of Recombinant Human/Simian Rotavirus in Cell Culture.VP4 突变增强重组人/猴轮状病毒在细胞培养中的复制
Viruses. 2024 Apr 5;16(4):565. doi: 10.3390/v16040565.
10
Correlates of immune protection against human rotaviruses: natural infection and vaccination.人体轮状病毒免疫保护的相关性:自然感染和疫苗接种。
Arch Virol. 2024 Mar 8;169(3):72. doi: 10.1007/s00705-024-05975-y.